High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas

MLA

Le Gouvello, S., et al. “High Prevalence of Foxp3 and IL17 in MMR-Proficient Colorectal Carcinomas.” Gut, vol. 57, no. 6, June 2008, p. 772. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.179946803&authtype=sso&custid=ns315887.

APA

Le Gouvello, S., Bastuji-Garin, S., Aloulou, N., Mansour, H., Chaumette, M.-T., Berrehar, F., Seikour, A., Charachon, A., Karoui, M., Leroy, K., Farcet, J.-P., & Sobhani, I. (2008). High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut, 57(6), 772.

Chicago

Le Gouvello, S., S. Bastuji-Garin, N. Aloulou, H. Mansour, M.-T. Chaumette, F. Berrehar, A. Seikour, et al. 2008. “High Prevalence of Foxp3 and IL17 in MMR-Proficient Colorectal Carcinomas.” Gut 57 (6): 772. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.179946803&authtype=sso&custid=ns315887.